Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression
Jieping Hu(Nanchang University), Zhiqun Shang(Second Hospital of Tianjin Medical University), Yuanjie Niu(Second Hospital of Tianjin Medical University), Shimiao Zhu(Second Hospital of Tianjin Medical University), Qiang Luo(Third People's Hospital of Chengdu), Libin Sun(Qingdao University), Jing Tian(Second Hospital of Tianjin Medical University), Hao Tian(Zhengzhou Normal University), Qian Dong(Daiichi Sankyo (United States)), Jianpeng Yu(Duke University), Ning Jiang(Second Hospital of Tianjin Medical University)
Cited by 73
Related Papers
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
|Journal of Clinical Oncology|2023|224
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
|Nucleic Acids Research|2019|212
Nuclear retention element recruits U1 snRNP components to restrain spliced lncRNAs in the nucleus
|RNA Biology|2019|108
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
|Journal of Experimental & Clinical Cancer Research|2020|106